Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients

被引:0
|
作者
Dorflinger, Charles [1 ]
LeHew, Colleen [1 ]
Carey, Heather [1 ]
Roche-Desilets, Jennifer [1 ]
Burant, Christopher J. [2 ,3 ]
机构
[1] VA Northeast Ohio Healthcare Syst, Pharm Dept, 10701 East Blvd, Cleveland, OH 44106 USA
[2] VA Northeast Ohio Healthcare Syst, Geriatr Res Educ & Clin Ctr, 10701 East Blvd, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA
关键词
MEDICATION ADHERENCE; SCHIZOPHRENIA; PREVALENCE;
D O I
10.1016/j.comppsych.2021.152269
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [21] A Subgroup Analysis of Chinese Patients Switched to Paliperidone Palmitate One-Month Injectable by Prior Oral Antipsychotic Treatment
    Si, T.
    Fan, J.
    Wang, X.
    Wang, C.
    Xu, C.
    Zhuo, J.
    Feng, Y.
    PHARMACOPSYCHIATRY, 2016, 49 (01) : 32 - 41
  • [22] Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics
    Hargarter, Ludger
    Cherubin, Pierre
    Bergmans, Paul
    Keim, Sofia
    Rancans, Elmars
    Bez, Yasin
    Parellad, Eduard
    Carpiniello, Bernardo
    Vidailhet, Pierre
    Schreiner, Andreas
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 58 : 1 - 7
  • [23] Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients Results From a Multicenter Retrospective Cohort Study in France
    Limosin, Frederic
    Belhadi, Drifa
    Comet, Denis
    Pacou, Maud
    Bouju, Sophie
    Van Impe, Kristel
    Guillon, Pascal
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (01) : 19 - 26
  • [24] Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
    Alphs, Larry
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Ma, Yi-Wen
    Sliwa, Jennifer Kern
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1029 - 1042
  • [25] Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
    Corbeil, Olivier
    Essiambre, Anne-Marie
    Bechard, Laurent
    Roy, Audrey-Anne
    Huot-Lavoie, Maxime
    Brodeur, Sebastien
    Chandrasena, Ranjith
    Theriault, Chantale
    Crocker, Candice
    Melun, Jean-Pierre
    Tibbo, Phil
    Demers, Marie-France
    Roy, Marc-Andre
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [26] Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
    Giron-Hernandez, Cesar
    Han, Joong Hee
    Alberio, Roberta
    Singh, Arun
    Garcia-Portilla, Maria Paz
    Pompili, Maurizio
    Knight, R. Karl
    Richarz, Ute
    Gopal, Srihari
    Antunes, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 895 - 906
  • [27] Effectiveness of Valsartan in Obese Versus Non-Obese Type 2 Diabetic patients presented with microalbuminuria
    Khan, Muhammad Kashif
    Khan, Shakeel
    Khan, Ahmad Shamim
    Sultan, Khawar
    Ahmad, Armughan
    Khalid, Usman
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2673 - 2675
  • [28] Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics
    Baser, Onur
    Xie, Lin
    Pesa, Jacqueline
    Durkin, Mike
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (05) : 357 - 365
  • [29] Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
    Oh, Jihoon
    Oh, Jihye
    Kim, Dong Wook
    Youn, HyunChul
    Kim, Sae-Hoon
    Kim, Soo In
    Chung, In Won
    Wang, Kuan Shu
    Kim, Minah
    Paik, Jong -Woo
    Koh, Min Jung
    Lee, Yoosun
    Choi, Seok Young
    Kim, Jung-Jin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (01) : 126 - 134
  • [30] Protocol proposal for switching long-acting antipsychotic medication in psychotic patients: from fluphenazine decanoate to paliperidone palmitate
    Boix, E.
    Niubo, M.
    Davi, E.
    Esteban, R.
    Moreno, L.
    Vilella, V.
    Alonso, I.
    Borras, M.
    Diez, O.
    Horta, A.
    Sobotkiewiczova, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S566 - S566